Singapore Airlines releases seven A350 jet orders back to Airbus
[SINGAPORE] Singapore Airlines has agreed to a request from Airbus to release seven of its A350-900 widebody jet orders back to the aircraft manufacturer, the carrier said in a statement.
This reduces the airline's A350s on order to 63, it said, in a series of adjustments to orders and deliveries to meet the immediate needs of the airline and the plane maker. Its purchase options for 20 of the wide-body A350-900s remain unchanged, the airline said.
The carrier also brought forward the deliveries of some of the other A350-900s it has on order and can extend the leases on some A330-300s it has in service, to meet its fleet renewal and growth plans, SIA said.
The airline also has orders for Boeing 777-300ERs and 787-10s, as well as Airbus A380 superjumbos.
On Wednesday, the SIA Group reported a first-quarter net profit of S$91.2 million ($66.6 million) for the three months to end-June, up from S$34.8 million a year before. Revenues were up slightly at S$3.73 billion versus S$3.68 billion.
Operating profit at the flagship full-service carrier increased to S$108 million from S$45 million, largely due to lower fuel costs and revenues from the sale of the seven production slots.
SIA's long-haul low-cost subsidiary Scoot lost S$20 million during the quarter, down from a loss of S$25 million a year before, and its cargo business remained in the red.
Looking ahead, SIA said that passenger and air cargo yields would remain under pressure in the July-September quarter due to a competitive environment and over-capacity.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Japan’s Sumitomo Corp net profit down 32% on Madagascar one-off loss
DBS customers unable to log into Digibank, PayLah! on Thursday
Moody's tops quarterly profit estimates on strong product demand
Hong Kong regulator brings insider trading charges against Segantii and its founder
Novartis to buy radiology specialist Mariana Oncology for US$1 billion
Moderna beats quarterly estimates as cost-cutting pares losses